STAT Plus: Argenx antibody drug improves symptoms in patients with myasthenia gravis
Argenx, a Belgian drug maker, said Tuesday that its experimental medicine improved the symptoms of…
Category: Biotech
AI systems are worse at diagnosing disease when training data is skewed by sex
The artificial intelligence model showed great promise in predicting which patients treated in U.S. Veterans…
Opinion: When bubonic plague hit France in 1720, officials dithered. Sound familiar?
On May 25, 1720, a ship named the Grand Saint-Antoine arrived in the port of…
Opinion: We need a national holiday to honor health policy
Let’s create a holiday for health policy. Not now. But eventually. A holiday that celebrates…
Opinion: When a Covid-19 vaccine becomes available, who should get it first?
The ethical challenges that have arisen so far in the coronavirus pandemic largely boil down…
Opinion: When a Covid-19 vaccine become available, who should get it first?
The ethical challenges that have arisen so far in the coronavirus pandemic largely boil down…
Covid-19 study details benefits of treatment with remdesivir, and also its limitations
Remdesivir, the only drug cleared to treat Covid-19, sped the recovery time of patients with…
FDA shuffles longtime division hed, Janet Woodcock, to focus exclusively on a Covid-19 vaccine project
WASHINGTON — Food and Drug Administration stalwart Janet Woodcock will temporarily step aside as the…
.jpg)
First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker
A drug maker in Bangladesh has become the first company to sell a generic version…
Early study of Covid-19 vaccine developed in China sees mixed results
A Covid-19 vaccine candidate being developed by a Chinese drug maker appeared to induce an…
STAT Plus: Phlow CEO speaks out on criticism of his record, plans for a drug ingredient stockpile, and a huge government contract
Earlier this week, the U.S. government awarded a $354 million contract to a new public…
What a big new study on malaria drugs as Covid-19 treatments tells us — and what it doesn’t
A new study underlines safety concerns about using the malaria drugs hydroxychloroquine and chloroquine to…
WHO warns millions of children at risk as Covid-19 pandemic disrupts routine vaccinations
Some 80 million babies around the world are at higher risk of diseases like diphtheria,…
Opinion: We need one response — not 50 — to fight Covid-19
In ordinary times, states handle the public health crises that affect their residents. That usually…
STAT Plus: Pharmalittle: Coronavirus vaccine may not be a cure-all; hydroxychloroquine fails in a Covid-19 study
And so, another working week will soon draw to a close. Not a moment too…
Opinion: All women should have access to the at-home test that can provide early detection of cervical cancer
My husband, our first-grade child, and I managed to get on what was likely one…
Opinion: To test our way out of the Covid-19 nightmare, focus on nursing homes
Less than 1% of Americans live in nursing homes, yet these facilities account for between…
STAT Plus: AI startup transcribes and annotates doctor visits for patients
Most attempts to use artificial intelligence to transcribe doctor visits are aimed at limiting documentation…
The world needs Covid-19 vaccines. It may also be overestimating their power
With a little luck and a lot of science, the world might in the not-too-distant…
Listen: Moderna’s scant coronavirus data, the plight of the day trader, and the world’s dependence on biotech
When is a press release worth $5 billion? Can biotech stocks replace sports? And how…
STAT Plus: In a tale of two Mercks, the German company wins a court battle over its U.S. rival
In a setback for Merck (MRK), a court in London ruled that the big drug…
Opinion: Recovery from Covid-19 is filled with uncertainty. An antibody test offered me a little comfort
There have been approximately 5 million confirmed cases of Covid-19 around the world. I’m one…
STAT Plus: After years of manufacturing problems, Akorn files for bankruptcy protection
After mounting financial and manufacturing woes, Akorn (AKRX) has filed for bankruptcy protection, a humbling…
U.S. gives up to $1.2 billion to AstraZeneca for Covid-19 vaccine
The race over funding and access to a Covid-19 vaccine is heating up as the…
Digital event: Confronting a Pandemic — Part 3
Editor’s note: The livestream will be embedded below at 1 p.m. ET. The need to…
STAT Plus: Pharmalittle: Trump’s Covid-19 vaccine chief has worrisome conflicts; U.S. provides $1.2 billion for AstraZeneca vaccine
Top of the morning to you, and a fine one it is. Once again, clear…
STAT Plus: Startup Spotlight: Aiming to speed precision cancer therapies to children
For some children with a certain type of brain tumor, treatment can mean surgery followed…
STAT Plus: Kadmon to seek FDA approval of drug targeting graft-versus-host disease following positive study outcome
Kadmon Holdings, the New York-based biotech, said Thursday that its experimental pill for chronic graft-versus-host…
Opinion: The growing global appetite for meat increases the risk of future ‘spillover’ pandemics. We can do something about it
I was a pandemic specialist for 15 years, leading projects under the emerging pandemic threats…
Opinion: Calling all health care workers ‘heroes’ harms all of us
Here’s an unjust fact: Some of the frontline health care workers we’ve been celebrating with…
‘It’s something I have never seen’: How the Covid-19 virus hijacks cells
A deep dive into how the new coronavirus infects cells has found that it orchestrates…
STAT Plus: A secret coup and a ‘poison pill’ have frozen shares of a biotech in the race for a Covid-19 vaccine
Moderna’s work on a vaccine for coronavirus has made its founders into paper billionaires. Gilead…
STAT Plus: Biosimilars got the cold shoulder from health plans when it came to preferred coverage
As debate rages over adoption of biosimilars in the U.S., a new analysis finds that…
Opinion: Life with lupus: Trump’s hydroxychloroquine hype puts my treatment — and himself — at risk
President Trump’s revelation this week that he’s taking hydroxychloroquine to ward off Covid-19 sent shivers…
STAT Plus: Pharmalittle: Experts say wait-and-see about Moderna’s Covid-19 vaccine; J&J will stop selling talc products in the U.S.
Hello, everyone, and welcome to the middle of the week. Time flies when you are…
Opinion: Lessons from the military on how to balance caring for patients against the risk of personal harm
“If not me, then who?” That was the answer Marine Corps First Lieutenant Travis Manion…
Opinion: Real-time data are essential for Covid-19. They’re just as important for the opioid overdose crisis
As the Covid-19 epidemic sweeps across the country leaving death and confusion in its wake,…
Federal legislation to protect health data has made little progress. Will that change in the Covid-19 era?
Before the Covid-19 pandemic, health data privacy wasn’t exactly a hot topic on Capitol Hill….
STAT Plus: Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO
Atul Gawande’s announcement last week that he was stepping down as CEO of a high-profile…
Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the…
STAT Plus: Amid conflict-of-interest criticisms, top FDA officials recuse themselves from Covid-19 vaccine approvals
A version of this article first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
As the chief executive of Phylo, the new company awarded $354 million by the federal government…
FDA, partnering with New York health tech firm, seeks to collect ‘real-world’ data on Covid-19
The Food and Drug Administration said Tuesday that it will launch a new research project…
STAT Plus: Pharmalittle: White House signs deal for U.S.-made generics to fight Covid-19; Gilead expands remdesivir donations
Rise and shine, another brand new day is here. Thanks to a sunny sky and…
STAT Plus: Moderna carries a big-boy market valuation now, so it shouldn’t act like a biotech penny stock
Some additional thoughts and comments on Moderna, its coronavirus vaccine, the stock’s valuation and Monday…
Opinion: Covid-19 has exposed the limits of the pharmaceutical market model
That so much hope is being pinned on remdesivir, the drug Gilead is testing for…
Opinion: Ventilators can save people with serious Covid-19. The people behind them are even more important
In mid-March, the day before I flew back to New York City to return to…
As Covid-19 lockdowns are lifted, uncertainty at nursing homes only deepens
It was late April when a Covid-19 outbreak was reported at the Seven Hills Health…
9 ways Covid-19 may forever upend the U.S. health care industry
WASHINGTON — In the U.S. alone, Covid-19 has claimed nearly 100,000 lives and 30 million…
Gilead ups its donation of the Covid-19 drug remdesivir for U.S. hospitals
Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number…